Cargando…

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

Detalles Bibliográficos
Autores principales:	Hoeks, Marlijn, Bagguley, Tim, van Marrewijk, Corine, Smith, Alex, Bowen, David, Culligan, Dominic, Kolade, Seye, Symeonidis, Argiris, Garelius, Hege, Spanoudakis, Michail, Langemeijer, Saskia, Roelofs, Rian, Wiegerinck, Erwin, Tatic, Aurelia, Killick, Sally, Panagiotidis, Panagiotis, Stanca, Oana, Hellström-Lindberg, Eva, Cermak, Jaroslav, van der Klauw, Melanie, Wouters, Hanneke, van Kraaij, Marian, Blijlevens, Nicole, Swinkels, Dorine W., de Witte, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179850/ https://www.ncbi.nlm.nih.gov/pubmed/32948844 http://dx.doi.org/10.1038/s41375-020-01022-2

Ejemplares similares

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
por: de Swart, Louise, et al.
Publicado: (2018)

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
por: Hoeks, Marlijn, et al.
Publicado: (2020)

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
por: de Witte, Theo, et al.
Publicado: (2020)

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes
por: de Swart, Louise, et al.
Publicado: (2020)

P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
por: Savic, Aleksandar, et al.
Publicado: (2023)

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
por: Stauder, Reinhard, et al.
Publicado: (2018)

EPO and hepcidin plasma concentrations in blood donors and β‐thalassemia intermedia are not related to commercially tested plasma ERFE concentrations
por: Schotten, Nienke, et al.
Publicado: (2017)

Investigating the Molecular Mechanisms of Renal Hepcidin Induction and Protection upon Hemoglobin-Induced Acute Kidney Injury
por: Diepeveen, Laura E., et al.
Publicado: (2022)

Kidney tubule iron loading in experimental focal segmental glomerulosclerosis
por: van Swelm, Rachel P. L., et al.
Publicado: (2022)

Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone
por: Diepeveen, Laura, et al.
Publicado: (2021)

Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group
por: Rochau, Ursula, et al.
Publicado: (2020)

NTBI levels in C282Y homozygotes after therapeutic phlebotomy
por: Ryan, Eleanor, et al.
Publicado: (2022)

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
por: Stojkov, Igor, et al.
Publicado: (2021)

Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome
por: Garelius, H. K. G., et al.
Publicado: (2016)

Effect of Eculizumab on Iron Metabolism in Transfusion-independent Patients With Paroxysmal Nocturnal Hemoglobinuria
por: Schaap, Charlotte C.M., et al.
Publicado: (2023)

A seven day running training period increases basal urinary hepcidin levels as compared to cycling
por: Sim, Marc, et al.
Publicado: (2014)

The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis
por: van Bommel, Erik JM, et al.
Publicado: (2021)

Association of anemia with health-related quality of life and survival: a large population-based cohort study
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2019)

Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment
por: Symeonidis, Argiris, et al.
Publicado: (2023)

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
por: Efficace, Fabio, et al.
Publicado: (2022)

Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform
por: Laarakkers, Coby M. M., et al.
Publicado: (2013)

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance
por: de Swart, Louise, et al.
Publicado: (2017)

PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY
por: Symeonidis, Argiris, et al.
Publicado: (2023)

Streptococcus gallolyticus Increases Expression and Activity of Aryl Hydrocarbon Receptor-Dependent CYP1 Biotransformation Capacity in Colorectal Epithelial Cells
por: Taddese, Rahwa, et al.
Publicado: (2021)

Low Hepcidin Levels in Severely Anemic Malawian Children with High Incidence of Infectious Diseases and Bone Marrow Iron Deficiency
por: Jonker, Femkje A. M., et al.
Publicado: (2013)

The Growth Attainment, Hematological, Iron Status and Inflammatory Profile of Guatemalan Juvenile End-Stage Renal Disease Patients
por: Casimiro de Almeida, Juliana, et al.
Publicado: (2015)

Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes
por: Symeonidis, Argiris, et al.
Publicado: (2022)

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges
por: Lazaris, Vasileios, et al.
Publicado: (2021)

Endogenous hepcidin synthesis protects the distal nephron against hemin and hemoglobin mediated necroptosis
por: van Swelm, Rachel P. L., et al.
Publicado: (2018)

Eggsplorer: a rapid plant–insect resistance determination tool using an automated whitefly egg quantification algorithm
por: Devi, Micha Gracianna, et al.
Publicado: (2023)

Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study
por: van Eijk, Lucas T, et al.
Publicado: (2011)

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management
por: Thomopoulos, Thomas P., et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
por: Symeonidis, Argiris, et al.
Publicado: (2022)

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes
por: Kouroukli, Olga, et al.
Publicado: (2022)

Hepcidin Status in Cord Blood: Observational Data from a Tertiary Institution in Belgium
por: Ceulemans, Michael, et al.
Publicado: (2023)

Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers
por: Pratt, Raymond D., et al.
Publicado: (2016)

Heparin-resistance in AL amyloidosis: a case report
por: van Ede, Elisabeth S., et al.
Publicado: (2023)

Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis
por: Goltstein, Lia C M J, et al.
Publicado: (2023)

The potential of individualized dosing of ravulizumab to improve patient‐friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs
por: ter Avest, Mendy, et al.
Publicado: (2021)

Iron Availability Increases the Pathogenic Potential of Salmonella Typhimurium and Other Enteric Pathogens at the Intestinal Epithelial Interface
por: Kortman, Guus A. M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c0vj24ov52lqdd06j99gnsqf4n